Waypoint Orthopedics

Waypoint Orthopedics is an early-stage medical device company targeting a significant unmet need in spine surgery: reducing harmful ionizing radiation exposure for surgical teams. Its flagship product, the FDA-approved Waypoint GPS, is a smart instrument that provides real-time guidance during pedicle screw placement, aiming to improve accuracy and safety in both open and minimally invasive (MIS) procedures. Backed by accelerator fund Runway Healthcare and founded by a surgeon, the company is positioned to address a large and growing spinal fixation market. Key challenges include navigating a competitive landscape, achieving commercial adoption, and demonstrating clear economic and clinical value to hospitals.

The Waypoint GPS (Guided Pedicle System) is a smart bone awl that integrates sensing technology to provide real-time feedback to surgeons during pedicle cannulation for screw placement, aiming to improve accuracy and reduce reliance on fluoroscopic radiation.

Waypoint competes in the spine surgical guidance segment against major integrated players like Medtronic (Mazor), Stryker (Mako, Q Guidance), and Globus Medical (ExcelsiusGPS) that offer robotic and advanced navigation systems. It also competes with other fluoroscopy-reduction technologies and traditional freehand techniques. Its differentiation lies in a potentially simpler, more focused, and lower-cost tool-based approach.